PODD | Insulet Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	264.80 - 270.29
52 Week Range	160.19 - 279.40
Beta	1.16
Implied Volatility	30.98%
IV Rank	9.39%
Day's Volume	137,581
Average Volume	595,758
Shares Outstanding	70,144,800
Market Cap	18,946,461,204
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2007-05-15

Valuation
Profitability
Growth
Health
P/E Ratio	46.01
Forward P/E Ratio	N/A
EPS	5.87
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	3,000
Country	USA
Website	PODD

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

PODD's peers: ALGN, BIO, DXCM, EW, GMED, INMD, INSP, MASI, MDT, NVCR, PEN, PHG, IART, SENS, TNDM, ABT, SYK, SWAV, TMDX, NARI, GKOS, QDEL, STE

*Chart delayed

Analyzing fundamentals for PODD we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is wealthy, Growth is exceptionally good and Health is passable. For more detailed analysis please see PODD Fundamentals page.

Watching at PODD technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PODD Technicals page.